CHOC selects newborn patient as candidate for international study to test the efficacy of Lacosamide in the treatment of neonatal seizures.
Nuclear Medicine program marks first year with nationally known director Dr. Hollie Lai leading the way
CHOC’s nuclear medicine program, under the direction of Dr. Hollie Lai, marks first year with sweeping success.
CHOC Research Day 2022 highlights how computing and data science is assisting clinicians
CHOC’s Research Day 2022 focused on how computing and data science holds promising solutions to challenges in pediatric medicine.
Attacking pediatric brain tumors from both sides: An oncologist’s perspective
CHOC’s multidisciplinary team provides integrative molecular diagnosis and customized treatment plans for children with brain and spine tumors.
Attacking pediatric brain tumors from both sides: A neurologist’s perspective
CHOC brings leading-edge initiatives to pediatric brain tumor treatment through a collaboration between neurology, neurosurgery and oncology.
Twins born at 22 weeks flourish following care in CHOC’s NICU
Learn how the CHOC NICU small baby unit cared for twins born prematurely at 22 weeks, enabling them to leave the hospital and thrive.